Mechanisms of pulmonary edema induced by a diacylglycerol second messenger.
We investigated the effect of dioctanoylglycerol (DOG), a second messenger of protein kinase C (PKC) activation, in the absence and presence of neutrophils in isolated perfused guinea pig lung. DOG was given after a base-line isogravimetric steady-state period. Pulmonary capillary pressure (Ppc) and change in lung weight (delta W) were monitored at 15, 30, and 60 min. Capillary filtration coefficient (Kf,c, an index of vascular permeability) was measured during base-line period and at 30 min. DOG increased the Ppc and delta W at 30 and 60 min, and the Kfc at 30 min. Monooctanoylglycerol, a monoacylglycerol that does not activate PKC, had no effect on Ppc, Kf,c, and delta W. Pretreatment with two different PKC inhibitors, 1-(5-isoquinolinylsulfonyl)-2-methyl piperazine or staurosporin, prevented the pulmonary response to DOG. With neutrophils present, DOG caused greater increases in delta W and the (wet-dry)-to-dry wt ratio compared with DOG group. Response to DOG+ neutrophils was due to oxygen radical production because it was prevented by pretreatment with catalase and because DOG increased superoxide release from neutrophils. PKC activation using DOG in the isolated lung results in pulmonary edema mediated by increases in capillary pressure and vascular permeability. Lung weight-gain response to DOG is greater in the presence of neutrophils. Response to DOG+ neutrophils is mediated by oxygen radicals.
Johnson
A
A
Research Service, Veterans Administration Medical Center, Albany, New York.
Hocking
D C
DC
Ferro
T J
TJ
D000818:Animals; D000838:Anions / Q000378:metabolism; D001696:Biomechanical Phenomena; D002199:Capillary Permeability / Q000187:drug effects; D004075:Diglycerides / Q000494:pharmacology / Q000502:physiology; D005260:Female; D005989:Glycerides / Q000494:pharmacology / Q000502:physiology; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008168:Lung / Q000033:anatomy & histology / Q000187:drug effects; D008297:Male; D009504:Neutrophils / Q000378:metabolism / Q000502:physiology; D009929:Organ Size / Q000187:drug effects; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011652:Pulmonary Circulation / Q000187:drug effects; D011654:Pulmonary Edema / Q000139:chemically induced*; D015290:Second Messenger Systems; D013481:Superoxides / Q000378:metabolism
D000838:Anions; D004075:Diglycerides; D005989:Glycerides; D013481:Superoxides; D011493:Protein Kinase C